Epithelial interferon-γ responsiveness shapes chemokine induction and clinical outcomes in herpes simplex virus infection
Open Access
- 30 September 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 22 (9) , e1014612
Abstract
Herpes simplex virus type 2 (HSV-2) infects genital epithelia and causes a wide spectrum of clinical outcomes, ranging from asymptomatic viral shedding to recurrent self-limited genital lesions. Interferon gamma (IFNγ) is critical in tissue-resident T-cell mediated antiviral defense against HSV-2 reactivation. However, the responsiveness of epithelial cells to IFNγ and its contribution to disease variability remains poorly understood. Here we investigated IFNγ-mediated antiviral responses in primary keratinocytes and donor-matched fibroblasts from individuals with either asymptomatic or ulcerative HSV-2 infection. Our results revealed that keratinocytes are remarkably sensitive to IFNγ, with altered gene expression observed at doses much lower than previously reported. Keratinocytes exhibited greater sensitivity to IFNγ stimulation than fibroblasts, including robust induction of chemokines involved in immune cell recruitment. Among them, CXCL10 was the most sensitive and strongly induced gene, displaying rapid upregulation even at low IFNγ concentrations. Notably, keratinocytes from individuals with asymptomatic HSV-2 infection exhibited significantly greater IFNγ responses at both the mRNA and protein levels compared with those from symptomatic donors, particularly at physiologically low IFNγ doses. This heightened responsiveness was associated with increased nuclear localization of phosphorylated STAT1 following IFNγ stimulation, despite similar baseline expression of IFNγ receptor and STAT1 across donor groups. While IFNγ pretreatment similarly inhibited HSV replication in keratinocytes from both cohorts, the enhanced chemokine production by keratinocytes from asymptomatic individuals may promote more efficient recruitment of antiviral immune cells. Together, these findings identify intrinsic variation in epithelial IFNγ signaling as a potential host factor associated with clinical outcomes in HSV infection. The results suggest that CXCL10-mediated immune recruitment might be a key mechanism linking tissue-resident T cell cytokine signaling to epithelial antiviral defense. Understanding variability in epithelial barrier immune defense may be crucial to improving therapies and vaccine strategies for genital herpes infection.Keywords
Funding Information
- Division of Microbiology and Infectious Diseases (AI007140)
- Division of Microbiology and Infectious Diseases (AI184778)
- Division of Microbiology and Infectious Diseases (AI143773)
This publication has 70 references indexed in Scilit:
- Altered increase in STAT1 expression and phosphorylation in severe COVID‐19European Journal of Immunology, 2021
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapyCancer Treatment Reviews, 2018
- Tissue-Resident Memory T CellsImmunity, 2014
- CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phaseJournal of Dermatological Science, 2013
- Interferon-stimulated genes and their antiviral effector functionsCurrent Opinion in Virology, 2011
- Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons With HSV-2 InfectionJAMA, 2011
- Role of IL-15 in immune-mediated and infectious diseasesCytokine & Growth Factor Reviews, 2011
- Effect of Pinus massoniana bark extract on IFN-γ-induced ICAM-1 expression in HaCaT human keratinocytesJournal of Ethnopharmacology, 2008
- Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15European Journal of Immunology, 2007
- Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10Journal of Neuroimmunology, 2006